Therapeutic effect of cabazitaxel and blood-brain barrier opening in a patient-derived glioblastoma model

Oppdragsgiver

• Regional Health Authority / 900000
• Liaison Committee between the Central Norway Regional health Authority (RHA) and the Norwegian University of Science and Technology (NTNU) / 90270600
• Research Council of Norway (RCN) / 240316

Forfatter(e)

• Einar Sulheim
• Ýrr Asbjørg Mørch
• Sofie Snipstad
• Sven Even Borgos
• Hrvoje Miletic
• Rolf Bjerkvig
• Catharina de Lange Davies
• Andreas Åslund

Institusjon(er)

• Norges teknisk-naturvitenskapelige universitet
• St. Olavs Hospital HF
• SINTEF Industri / Bioteknologi og nanomedisin
• Universitetet i Bergen
• Helse Bergen HF - Haukeland universitetssykehus
• Luxembourg Institute of Health

Hefte nr.

1

DOI

Les fulltekst